Integrated Supported Biopsychosocial Self-Management for Back Related Leg Pain

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

February 20, 2023

Study Completion Date

February 20, 2023

Conditions
Low Back PainSciaticaBack Related Leg PainPain, ChronicIntervertebral Disc Displacement
Interventions
BEHAVIORAL

Supported Biopsychosocial Self-Management (SBSM)

Participants receive training and instruction in skills to engage in healthy physical, psychological, and social self-management behaviors. This will be accomplished through 6-12 sessions with a trained chiropractor or physical therapist. Patients will receive training and instruction in exercises targeting posture, strength, stabilization, and mobility based on their individual needs. They will learn psychological strategies including problem solving and cognitive restructuring to address unhelpful thoughts and emotions. Social strategies include pleasant activity planning with a social focus, and communication techniques for navigating relationships to garner support for self-sufficiency. Other elements include providing key evidence based information about BRLP and spinal manipulation therapies (SMT). SMT will include manipulation, mobilization and soft-tissue treatment. Other intervention elements include enablement, persuasion, and resources and materials to support the patient.

DRUG

Medical Care

Medical care will be comprised of primarily medication management, which is a standard first-line approach for back-related leg pain in primary care. Choice of medications is informed by the current evidence and the American College of Physicians guidelines on noninvasive treatment for LBP which balances evidence for risks and benefits when making recommendations. Decisions regarding medication selection will be made collaboratively between the study provider and patient after a discussion of risk/benefit profiles and patient preferences, including prior response. Study providers licensed to prescribe FDA-approved medications will call-in the prescription for the medication of choice to the participant's preferred pharmacy, as is typical in clinical practice.

Trial Locations (2)

15260

University of Pittsburgh, Pittsburgh

55455

University of Minnesota, Minneapolis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

collaborator

Duke University

OTHER

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of Minnesota

OTHER